If you ever want to look for value in a sector in the stock market, then when you see Congress calling in some of the top companies to scold them for political…
After Pfizer and Merck released their most recent earnings reports last week, analysts weighed in on both of these pharmaceutical giants.
Needless to say, the stock market can be a very cruel mistress. So what are patient long-term investors to do?
Pfizer reported better-than-expected fourth-quarter and full-year 2015 results before markets opened Tuesday morning.
Paul Ausick Pfizer is scheduled to report its fourth-quarter financial results before the markets open on Tuesday.
Chris Lange 24/7 Wall St. has put together a preview of the three Dow Jones Industrial Average companies that are reporting their quarterly results this week.
Some of the Dow stocks that are down in 2016 haven't even reported earnings. This is the market bracing for bad news, but one cannot wonder if that means that the earnings…
Needless to say, the stock market can be a very cruel mistress. Companies can report great numbers, but if the guidance is light? Look out!
The January 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
Perhaps not surprisingly, in early January, short interest was on the rise for most of the top six most heavily shorted stocks traded on the New York Stock Exchange.
These stocks are not exciting, but neither are market sell-offs and big paper losses like we have seen in January.
Thursday's top analyst calls include Alcoa, GoPro, MetLife, Netflix, SUPERVALU, Walt Disney, Williams Companies and Yelp.
A bull market interrupted is how many investors likely feel at the start of 2016. These are the seven Dow stocks that will be needed to drive the Dow higher in 2016.
The short interest data have been released for the December 31 settlement date. For most of the selected pharmaceutical stocks short interest was up.
General Electric saw its short interest drop sharply between the December 15 and December 31 settlement dates for the second period in a row. Meanwhile, short sellers piled on to Pfizer and…
